RxSight chief business development officer Eric Weinberg sells $14,205 in stock By Investing.com
Horizon Kinetics holding corp director Alice Brennan buys $5,200 stock By Investing.com

Alice C. Brennan, a director at Horizon Kinetics Holding Corp (), purchased shares of the company’s common stock on August 27, 2026.
Ms. Brennan acquired 200 shares at a price of $26.0 per share, totaling $5,200. The purchase comes as the stock trades at a P/E ratio of 10.4, and InvestingPro analysis suggests the company is currently undervalued relative to its Fair Value—placing it among stocks on the most undervalued list. Following this transaction, her direct beneficial ownership in Horizon Kinetics Holding Corp stands at 1,600 shares. The company maintains a healthy balance sheet with more cash than debt, according to InvestingPro Tips, which offers 5 additional exclusive insights for HKHC investors.
In other recent news, Horizon Kinetics reported its financial results for the second quarter of 2026, revealing a wider GAAP loss. The company disclosed a net loss attributable to shareholders of $18.4 million, or $0.99 per share. This occurred despite the growth in some of its fee-based businesses. The management and advisory revenues were $18.8 million, remaining essentially unchanged from the previous year. The company attributed the increased loss to investment volatility and redeemable non-controlling interests. These developments are part of the latest updates from Horizon Kinetics.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
